$ORIC Oric Pharmaceuticals, Inc. Insider Trading Week 12/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Oric Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Oric Pharmaceuticals, Inc. in week 12/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 23.88 | 27,816 | 664,246 | 2,315,995 | 2.3 M to 2.3 M (-1.19 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.70 | 51,523 | 1,272,618 | 2,343,811 | 2.4 M to 2.3 M (-2.15 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 26 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.80 | 32,959 | 817,383 | 2,395,334 | 2.4 M to 2.4 M (-1.36 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | GORDON CARL L | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 24.32 | 3,992 | 97,085 | 2,428,293 | 2.4 M to 2.4 M (-0.16 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 7,673 | 203,104 | 2,432,285 | 2.4 M to 2.4 M (-0.31 %) |
Mar 23 2021 | ORIC | Oric Pharmaceutica ... | ORBIMED ADVISORS LLC | Director | Sell | S | 26.47 | 21,275 | 563,149 | 2,439,958 | 2.5 M to 2.4 M (-0.86 %) |